Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT02000063




Registration number
NCT02000063
Ethics application status
Date submitted
12/11/2013
Date registered
3/12/2013
Date last updated
1/10/2014

Titles & IDs
Public title
Australian Trial in Acute Hepatitis C Recall Study
Scientific title
Long-term Outcomes Following Treatment of Recently Acquired Hepatitis C Virus Infection.
Secondary ID [1] 0 0
VHCRP1105
Secondary ID [2] 0 0
VHCRP1105
Universal Trial Number (UTN)
Trial acronym
ATAHC Recall
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute Hepatitis C 0 0
Condition category
Condition code
Infection 0 0 0 0
Other infectious diseases
Oral and Gastrointestinal 0 0 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Long-term effects of HCV clearance
Timepoint [1] 0 0
4 to 8 years from initial infection
Secondary outcome [1] 0 0
Incidence of HCV re-infection
Timepoint [1] 0 0
4 to 8 years from initial infection

Eligibility
Key inclusion criteria
- Previous enrolment in the Australian Trial of Acute Hepatitis C Virus Infection
(ATAHC) Study.

- Provision of written, informed consent.
Minimum age
16 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- In the opinion of the investigator that the patient is not able to provide informed
consent.

- Inability or unwillingness to comply with study collection requirements.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/08/2012
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/03/2014
Sample size
Target
Accrual to date
Final
50
Recruitment in Australia
Recruitment state(s)
NSW,SA,VIC
Recruitment hospital [1] 0 0
St Vincent's Hospital - Sydney
Recruitment hospital [2] 0 0
Royal Adelaide Hospital - Adelaide
Recruitment hospital [3] 0 0
The Alfred Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
2010 - Sydney
Recruitment postcode(s) [2] 0 0
5000 - Adelaide
Recruitment postcode(s) [3] 0 0
3005 - Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
Kirby Institute
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
The University of New South Wales
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
A single long-term follow up assessment of an established multi-centre, prospective
longitudinal cohort study of patients for clinical, psychosocial, immunovirological outcomes
4 to 8 years after previous treatment for recently acquired hepatitis C virus infection.
Trial website
https://clinicaltrials.gov/ct2/show/NCT02000063
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Gail Matthews, MBChB, MRCP (UK), FRACP, PhD
Address 0 0
University of New South Wales, Syndey Australia
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries